Table 1.

The change in saturation ratio (R _sat) of individual phospholipid fractions in erythrocytic membranes of patients with stable angina (SA) and SA with hypertension (HT) on the background of treatment (means ± SD).

Variants of experiments	R sat PC, µg Ppch/mg Pfl	R sat PEA, µg Ppea/mg Pfl	R sat SM µg Psm/mg Pfl	R sat PS µg Pps/mg Pfl	R sat PI µg Ppi/mg Pfl	R sat DAG µg Pdag/mg Pfl	R sat FFA µg Pffa/mg Pfl
Donors	1.05 ± 0.021	1.3 ± 0.038	1.7 ± 0.021	1.2 ± 0.023	1.2 ± 0.021	1.95 ± 0.022	1.1 ± 0.02
Patients with SA before treatment	1.65 ± 0.06∗	2.86 ± 0.069∗	3.23 ± 0.055∗	1.8 ± 0.051	2.34 ± 0.056∗	2.71 ± 0.69∗	2.26 ± 0.094∗
Patients with SA+HT before treatment	1.77 ± 0.067∗	3.92 ± 0.066∗	3.84 ± 0.05∗	2.24 ± 0.044∗	2.87 ± 0.058∗	2.89 ± 0.061∗	3.21 ± 0.062∗
Patients with SA after treatment	1.29 ± 0.063∗∗	2.09 ± 0.082	2.58 ± 0.075∗∗	1.49 ± 0.06	1.62 ± 0.066	2.45 ± 0.089	1.58 ± 0.076∗∗
Patients with SA+HT after treatment	1.45 ± 0.047∗∗	3.02 ± 0.079∗∗	3.26 ± 0.026	1.93 ± 0.078	1.95 ± 0.078∗∗	2.64 ± 0.079	2.41 ± 0.043∗∗

^∗Reliability in relation to donors' indicators.

^∗∗Reliability in relation to pretreatment indicators at p < 0.05.